How I Treat: First-Line Therapy for Chronic Lymphocytic Leukemia in the Era of BTK Inhibition

Dr. Mazyar Shadman introduces the program on first-line CLL therapy in the era of BTK inhibition, joined by Dr. Andrew Lipsky.

Dr. Shadman explains that high-risk definitions evolve as treatments change.